<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT931-12138</title>
	</head>
	<body>
		<main>
			<p>930129 FT  29 JAN 93 / International Company News: Rhone-Poulenc division lifts profits to Dollars 428m RHONE-Poulenc Rorer, the separately stock market listed pharmaceuticals division of Rhone-Poulenc, the French chemicals group, yesterday reported a 31 per cent increase in net profits for last year. The Franco-American group made Dollars 428m last year on sales of Dollars 4.1bn, up from net profits of Dollars 326m on sales of Dollars 3.8bn. Sales rose by an underlying 8.4 per cent, stripping out currency changes and asset sales, while earnings per share rose from Dollars 2.3 to Dollars 3.1. Mr Robert Cawthorn, group chairman, said earnings growth was faster than the pharmaceuticals industry average. Rhone-Poulenc Rorer had also increased spending on research and development. Operating profits increased from Dollars 558m to Dollars 675m, while capital gains from asset sales fell to Dollars 23m from Dollars 95m. CAISSE Nationale de Credit Agricole has increased its stake in Banco Ambrosiana Veneto to 15.76 per cent, buying a 2.72 per cent stake from Gemina for FFr320m, Reuter reports from Paris.</p>
		</main>
</body></html>
            